Replies to post #248756 on Anavex Life Sciences Corp (AVXL)

[mike_dotcom]

" just wish I had a time machine to fast forward." Fast forward far enough and we'll all be dead.

[nidan7500]

WE GOT THIS......stay tuned

Systematic review: The authors reviewed the literature using PubMed, clinicaltrials.gov, and relevant Alzheimer's disease (AD) meeting abstracts and presentations. This study is, to the best of our knowledge, the first reported genome-wide search for biomarkers associated with drug response in AD.
Interpretation of results: Our findings have led to the identification of two genomic variants and a clinical baseline to pre-specify patients most likely to respond to a SIGMAR1 therapy using blarcamesine.

Future directions: The findings from this analysis have led to an ongoing confirmatory, randomized, and placebo-controlled Phase 2b/3 study investigating blarcamesine in 450 subjects (NCT03790709).

They know exactly what to look for and can predict w/confidence what the trial outcome will be...no more FIRE>>>>READY>>>>AIM